Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Non-Current Assets: 2022-2025

Historic Other Non-Current Assets for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Sep 2025 value amounting to $1.3 million.

  • Orchestra BioMed Holdings' Other Non-Current Assets fell 0.54% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 0.54%. This contributed to the annual value of $1.0 million for FY2024, which is 32.64% up from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Other Non-Current Assets stood at $1.3 million for Q3 2025, which was up 1.57% from $1.3 million recorded in Q2 2025.
  • Orchestra BioMed Holdings' Other Non-Current Assets' 5-year high stood at $4.7 million during Q4 2022, with a 5-year trough of $421,000 in Q1 2023.
  • Moreover, its 3-year median value for Other Non-Current Assets was $894,000 (2024), whereas its average is $929,545.
  • In the last 5 years, Orchestra BioMed Holdings' Other Non-Current Assets crashed by 83.68% in 2023 and then skyrocketed by 115.73% in 2024.
  • Orchestra BioMed Holdings' Other Non-Current Assets (Quarterly) stood at $4.7 million in 2022, then slumped by 83.68% to $769,000 in 2023, then spiked by 32.64% to $1.0 million in 2024, then decreased by 0.54% to $1.3 million in 2025.
  • Its Other Non-Current Assets was $1.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.3 million in Q1 2025.